{"schema_version":"1","generated_at":"2026-11-06T11:26:11.465Z","data_as_of":null,"url":"https://www.findmykol.com/kol/shruti-pandita","json_url":"https://www.findmykol.com/kol/shruti-pandita/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"shruti-pandita","name":"Shruti Pandita","credential":"MD","specialty":"Medical Oncology","specialty_raw":"Medical Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"San Antonio","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1689093015","orcid":"0000-0001-6555-2760","openalex":"A5046655975"},"summary":"Shruti Pandita is an Oncology physician. OpenAlex indexes 22 publications with 850 citations (h-index 11).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":22,"cited_by_count":850,"h_index":11,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":2,"program_years":{"first":2021,"last":null},"rows_total":3,"shown":3,"withheld":0,"rows":[{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2025,"amount_usd":43.25,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1689093015"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2024,"amount_usd":525,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1689093015"},{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2022,"amount_usd":121.9,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1689093015"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1689093015","source":"payments"},"prescribing":{"data_year":2023,"areas_total":3,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":61.8,"classes_total":1,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"mixed","share_pct":61.8,"drugs":[{"name":"Ondansetron hydrochloride","share_pct":97.7},{"name":"Ondansetron Hcl","share_pct":2.3}],"max_beneficiaries":29}]},{"area":"Sensory organs","share_pct":35.8,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"administered","share_pct":35.8,"drugs":[{"name":"Dexamethasone sodium phosphate","share_pct":100}],"max_beneficiaries":24}]},{"area":"Nervous system","share_pct":2.4,"classes_total":1,"classes":[{"class":"Phenothiazine","setting":"prescribed","share_pct":2.4,"drugs":[{"name":"Prochlorperazine Maleate","share_pct":100}],"max_beneficiaries":13}]}],"care_setting":{"dominant":"office","data_year":2023,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":22,"shown":5,"withheld":17,"matched_by":"OpenAlex author record","recent":[{"title":"A predictive chromatin architecture nexus regulates transcription and DNA damage repair","year":2025,"journal":"Journal of Biological Chemistry","source_url":"https://doi.org/10.1016/j.jbc.2025.108300","status":"verified"},{"title":"Advances in Artificial Intelligence for Glioblastoma Radiotherapy Planning and Treatment","year":2025,"journal":"Cancers","source_url":"https://doi.org/10.3390/cancers17233762","status":"verified"},{"title":"Epigenetic–Metabolic Interplay in the DNA Damage Response and Therapeutic Resistance of Breast Cancer","year":2023,"journal":"Cancer Research","source_url":"https://doi.org/10.1158/0008-5472.can-22-3015","status":"verified"},{"title":"Digital twin","year":2023,"journal":"Elsevier eBooks","source_url":"https://doi.org/10.1016/b978-0-12-824010-6.00051-4","status":"verified"},{"title":"Is dual immunotherapy needed in first-line treatment of microsatellite instability (MSI)-high metastatic colorectal cancer?","year":2023,"journal":"Annals of Palliative Medicine","source_url":"https://doi.org/10.21037/apm-22-1426","status":"verified"}],"source":"works"},"contact":{"address_1":"7979 WURZBACH RD","city":"San Antonio","state":"TX","zip":"782294427","phone":"314-577-6057","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1689093015","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":17}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-02-16","provider_certified":"2022-02-16","collected_at":"2026-11-05T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2023}},"methodology_url":"https://www.findmykol.com/about#methodology"}